Financial Management Professionals, Inc.
Position in GILD — Gilead Sciences, Inc.
CIK 1568132
AUSTIN, TX
Position in GILD
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$914,575
-$111,327 QoQ
Shares Held
7,239
-1.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.63%
of 13F equity value
Holder Rank
#1,112
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Financial Management Professionals, Inc. holds $5,803,019 across 15 Drug Manufacturers - General names. GILD ranks #3 (15.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
6,071 | $1,527,706 | |
| 2 | LLY |
ELI LILLY & Co
|
933 | $1,119,068 | |
| 3 | GILD |
Gilead Sciences, Inc.
This page
|
7,239 | $914,575 | |
| 4 | JNJ |
Johnson & Johnson
|
3,299 | $837,847 | |
| 5 | AMGN |
Amgen Inc
|
1,624 | $588,082 | |
| 6 | MRK |
Merck & Co., Inc.
|
3,783 | $486,115 | |
| 7 | PFE |
Pfizer Inc
|
4,666 | $112,357 | |
| 8 | NVS |
Novartis AG
|
562 | $88,076 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $914,575 | 7,239 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $1,025,902 | 7,361 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $871,944 | 7,104 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $789,432 | 7,112 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $783,074 | 7,063 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $838,582 | 7,484 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $672,084 | 7,276 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $535,653 | 6,389 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $432,037 | 6,297 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $430,563 | 5,878 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $446,932 | 5,517 | Shares | Sole | 2024-01-12 | |
| 2023-09-30 | $370,578 | 4,945 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $332,865 | 4,319 | Shares | Sole | 2023-07-10 | |
| 2023-03-31 | $341,919 | 4,121 | Shares | Sole | 2023-04-13 | |
| 2022-12-31 | $442,213 | 5,151 | Shares | Sole | 2023-01-11 | |
| 2022-09-30 | $273,903 | 4,440 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $254,471 | 4,117 | Shares | Sole | 2022-07-12 | |
| 2022-03-31 | $209,977 | 3,532 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $167,946 | 2,313 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $154,298 | 2,209 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $152,869 | 2,220 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $106,316 | 1,645 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $88,788 | 1,524 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $93,521 | 1,480 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $113,024 | 1,469 | Shares | Sole | 2020-07-21 | |
| 2020-03-31 | $26,166 | 350 | Shares | Sole | 2020-04-24 | |
| No filing history on record for this holder in this stock. | ||||||